Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 10 | 2026 | 1419 | 3.070 |
Why?
|
| DNA Helicases | 4 | 2026 | 239 | 2.740 |
Why?
|
| DNA-Binding Proteins | 6 | 2026 | 1939 | 2.600 |
Why?
|
| PTEN Phosphohydrolase | 5 | 2023 | 252 | 1.410 |
Why?
|
| Repressor Proteins | 2 | 2026 | 760 | 1.350 |
Why?
|
| Nuclear Proteins | 2 | 2026 | 1211 | 1.190 |
Why?
|
| B7 Antigens | 2 | 2026 | 17 | 1.160 |
Why?
|
| Cell Line, Tumor | 14 | 2026 | 3748 | 1.110 |
Why?
|
| Coenzyme A Ligases | 1 | 2026 | 14 | 0.970 |
Why?
|
| Immunoconjugates | 1 | 2026 | 41 | 0.940 |
Why?
|
| Tumor Escape | 3 | 2021 | 65 | 0.930 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2025 | 8 | 0.900 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2026 | 722 | 0.880 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2025 | 167 | 0.820 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2025 | 105 | 0.800 |
Why?
|
| Bone Neoplasms | 2 | 2025 | 475 | 0.780 |
Why?
|
| Macrophages | 2 | 2025 | 667 | 0.770 |
Why?
|
| Cholesterol | 1 | 2025 | 539 | 0.730 |
Why?
|
| Aurora Kinase A | 1 | 2022 | 37 | 0.720 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2022 | 248 | 0.660 |
Why?
|
| Gene Expression Regulation, Neoplastic | 9 | 2026 | 2026 | 0.650 |
Why?
|
| Cell Cycle Proteins | 2 | 2022 | 710 | 0.650 |
Why?
|
| Tumor Microenvironment | 4 | 2022 | 713 | 0.530 |
Why?
|
| Mice | 15 | 2026 | 18301 | 0.500 |
Why?
|
| Genes, Essential | 1 | 2017 | 39 | 0.500 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2017 | 200 | 0.480 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 121 | 0.470 |
Why?
|
| Animals | 17 | 2026 | 33912 | 0.420 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2026 | 1011 | 0.400 |
Why?
|
| DNA Damage | 2 | 2026 | 511 | 0.380 |
Why?
|
| Genomics | 1 | 2017 | 1621 | 0.290 |
Why?
|
| Male | 13 | 2026 | 64957 | 0.280 |
Why?
|
| Smad4 Protein | 2 | 2020 | 59 | 0.270 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2021 | 196 | 0.250 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2026 | 26 | 0.240 |
Why?
|
| Humans | 20 | 2026 | 131163 | 0.230 |
Why?
|
| Purines | 1 | 2026 | 118 | 0.230 |
Why?
|
| Diazepam Binding Inhibitor | 1 | 2025 | 1 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2026 | 188 | 0.220 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2025 | 90 | 0.220 |
Why?
|
| Androgen Antagonists | 1 | 2025 | 105 | 0.210 |
Why?
|
| Colorectal Neoplasms | 2 | 2022 | 621 | 0.210 |
Why?
|
| Oxidative Phosphorylation | 1 | 2025 | 142 | 0.210 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2025 | 78 | 0.210 |
Why?
|
| Cellular Reprogramming | 1 | 2025 | 129 | 0.200 |
Why?
|
| Pancreatic Neoplasms | 2 | 2021 | 740 | 0.190 |
Why?
|
| Endothelium, Vascular | 1 | 2026 | 468 | 0.190 |
Why?
|
| Sp1 Transcription Factor | 1 | 2023 | 39 | 0.190 |
Why?
|
| Androgens | 1 | 2025 | 247 | 0.190 |
Why?
|
| CTLA-4 Antigen | 1 | 2023 | 65 | 0.190 |
Why?
|
| Up-Regulation | 2 | 2023 | 825 | 0.190 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2022 | 45 | 0.180 |
Why?
|
| CRISPR-Cas Systems | 1 | 2025 | 317 | 0.180 |
Why?
|
| Receptors, Androgen | 1 | 2025 | 408 | 0.180 |
Why?
|
| Mutation | 2 | 2026 | 6099 | 0.180 |
Why?
|
| Dioxygenases | 1 | 2022 | 69 | 0.180 |
Why?
|
| Neoplasms | 1 | 2017 | 3016 | 0.170 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2020 | 619 | 0.170 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2021 | 109 | 0.170 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2021 | 105 | 0.170 |
Why?
|
| Disease Progression | 3 | 2023 | 2200 | 0.160 |
Why?
|
| B7-H1 Antigen | 1 | 2021 | 136 | 0.160 |
Why?
|
| Epigenesis, Genetic | 1 | 2025 | 757 | 0.150 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2019 | 9 | 0.150 |
Why?
|
| Synthetic Lethal Mutations | 1 | 2019 | 10 | 0.150 |
Why?
|
| Interferon Regulatory Factor-2 | 1 | 2019 | 4 | 0.150 |
Why?
|
| Paracrine Communication | 1 | 2019 | 69 | 0.140 |
Why?
|
| Telomere | 1 | 2020 | 219 | 0.140 |
Why?
|
| Atherosclerosis | 1 | 2026 | 948 | 0.140 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2019 | 144 | 0.130 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 176 | 0.130 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 2326 | 0.130 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2019 | 127 | 0.130 |
Why?
|
| Synthetic Biology | 1 | 2017 | 14 | 0.130 |
Why?
|
| Cell Differentiation | 1 | 2025 | 1928 | 0.130 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 633 | 0.130 |
Why?
|
| Phosphorylation | 2 | 2020 | 1571 | 0.130 |
Why?
|
| beta-Transducin Repeat-Containing Proteins | 1 | 2017 | 6 | 0.130 |
Why?
|
| Malate Dehydrogenase | 1 | 2017 | 6 | 0.130 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2019 | 821 | 0.130 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2017 | 62 | 0.120 |
Why?
|
| Protein Stability | 1 | 2017 | 165 | 0.120 |
Why?
|
| Methylation | 1 | 2017 | 199 | 0.120 |
Why?
|
| Lysine | 1 | 2017 | 167 | 0.120 |
Why?
|
| Ubiquitination | 1 | 2017 | 173 | 0.120 |
Why?
|
| Chemokine CXCL5 | 1 | 2015 | 7 | 0.120 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2017 | 241 | 0.120 |
Why?
|
| Proteolysis | 1 | 2017 | 200 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 588 | 0.110 |
Why?
|
| Myeloid Cells | 1 | 2015 | 113 | 0.110 |
Why?
|
| Antineoplastic Agents | 2 | 2022 | 1826 | 0.110 |
Why?
|
| NF-kappa B | 1 | 2017 | 440 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 639 | 0.100 |
Why?
|
| Glioma | 1 | 2019 | 494 | 0.100 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 386 | 0.100 |
Why?
|
| Biomarkers, Tumor | 2 | 2019 | 1586 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2017 | 767 | 0.100 |
Why?
|
| Histones | 1 | 2017 | 541 | 0.100 |
Why?
|
| Inflammation | 1 | 2020 | 1489 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 1306 | 0.080 |
Why?
|
| Neoplasm Metastasis | 2 | 2025 | 713 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 4697 | 0.070 |
Why?
|
| Wnt Signaling Pathway | 2 | 2022 | 223 | 0.070 |
Why?
|
| Reactive Oxygen Species | 2 | 2025 | 521 | 0.070 |
Why?
|
| Mice, SCID | 2 | 2019 | 585 | 0.070 |
Why?
|
| Receptors, Interleukin-8B | 2 | 2019 | 15 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 4738 | 0.060 |
Why?
|
| Signal Transduction | 4 | 2020 | 4686 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2019 | 801 | 0.060 |
Why?
|
| Cell Movement | 2 | 2019 | 876 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 2602 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2025 | 436 | 0.050 |
Why?
|
| DNA Repair | 1 | 2026 | 571 | 0.050 |
Why?
|
| Tryptophan Oxygenase | 1 | 2022 | 3 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2025 | 377 | 0.050 |
Why?
|
| Tryptophan | 1 | 2022 | 84 | 0.050 |
Why?
|
| Lipid Metabolism | 1 | 2025 | 387 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2021 | 292 | 0.040 |
Why?
|
| beta Catenin | 1 | 2022 | 197 | 0.040 |
Why?
|
| Caspase 1 | 1 | 2020 | 50 | 0.040 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2020 | 94 | 0.040 |
Why?
|
| Interleukin-18 | 1 | 2020 | 75 | 0.040 |
Why?
|
| Female | 4 | 2025 | 70963 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2020 | 356 | 0.040 |
Why?
|
| Protein Precursors | 1 | 2020 | 140 | 0.040 |
Why?
|
| Telomerase | 1 | 2020 | 154 | 0.040 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2019 | 8 | 0.040 |
Why?
|
| THP-1 Cells | 1 | 2019 | 22 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2019 | 49 | 0.040 |
Why?
|
| Integrin beta1 | 1 | 2019 | 51 | 0.040 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2019 | 26 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 1205 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2019 | 138 | 0.040 |
Why?
|
| Chemokines, CXC | 1 | 2019 | 38 | 0.040 |
Why?
|
| Osteopontin | 1 | 2019 | 55 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 1071 | 0.040 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2019 | 57 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 240 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 299 | 0.030 |
Why?
|
| Gene Fusion | 1 | 2018 | 58 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2019 | 2406 | 0.030 |
Why?
|
| Colon | 1 | 2020 | 373 | 0.030 |
Why?
|
| Oncogenes | 1 | 2018 | 164 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 274 | 0.030 |
Why?
|
| Pregnancy Proteins | 1 | 2017 | 17 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2017 | 37 | 0.030 |
Why?
|
| Ketoglutaric Acids | 1 | 2017 | 26 | 0.030 |
Why?
|
| Biocatalysis | 1 | 2017 | 38 | 0.030 |
Why?
|
| NADP | 1 | 2017 | 57 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2017 | 31 | 0.030 |
Why?
|
| Transaminases | 1 | 2017 | 38 | 0.030 |
Why?
|
| Gastrointestinal Diseases | 1 | 2020 | 343 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2018 | 700 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 419 | 0.030 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2017 | 75 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2019 | 573 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2021 | 768 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2018 | 357 | 0.030 |
Why?
|
| Prostate | 1 | 2018 | 404 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2020 | 771 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2017 | 170 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2018 | 336 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2015 | 448 | 0.020 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 842 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2019 | 2465 | 0.020 |
Why?
|
| Mitochondria | 1 | 2017 | 785 | 0.020 |
Why?
|
| Prognosis | 1 | 2018 | 4886 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 2596 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 10103 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 21025 | 0.010 |
Why?
|
| Child | 1 | 2020 | 26341 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 28601 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 31282 | 0.010 |
Why?
|